SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

TYCHE INDUSTRIES

BSE: 532384 29 Jun 2025
Healthcare
₹ 135.9
Tyche Industries Ltd. specializes in Pharmaceuticals within the Healthcare sector.

TYCHE INDUSTRIES - Share Price & Details

Market Cap
₹142.0
High /Low
224.0 / 129.0
Stock P/E
11.4
Book Value
₹133.0
Dividend Yield
1.81
ROCE
12.7
ROE
₹9.42
Face Value
10.0
PEG Ratio
-1.7
EVEBITDA
₹3.07
Debt
0.00
CMP / FCF
24.9
Debt to equity
₹0.0
NP Ann
12.4
High price all time
350.0
Piotroski score
₹5.0
Graham Number
191.0
No. Eq. Shares
1.02
Net CF
₹5.37
Net profit
12.4
Price to book value
1.04
Interest Coverage
₹NA
Low price all time
6.39
Industry PE
32.7
Reserves
₹126
Free Cash Flow
₹7.84

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
TYCHE INDUSTRIES LTD.NANANANA142.011.4
LACTOSE (INDIA) LTD.NANANANA14127.3
DENIS CHEM LAB LTDNANANANA14117.5

Peer Comparison Chart


About TYCHE INDUSTRIES

Tyche Industries Ltd., with Security Code 532384, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Tyche Industries Faces Financial Challenges Amid Mixed Valuation Metrics and Trends

(05 Jun 2025)
Tyche Industries, a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting...
Read more →

Tyche Industries standalone net profit declines 55.24% in the March 2025 quarter

(29 May 2025)
Sales decline 12.89% to Rs 12.37 crore. Net profit of Tyche Industries declined 55.24% to Rs 0.94 crore in the quarter ended March 2025 as...
Read more →

BOARD OF TYCHE INDUSTRIES RECOMMENDS FINAL DIVIDEND

(29 May 2025)
Tyche Industries announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the...
Read more →

Tyche Industries Reports Decline in Sales and Profitability for March 2025

(29 May 2025)
Tyche Industries has announced its financial results for the quarter ending March 2025, revealing a decline in net sales and profitability...
Read more →

India's Aspen Biopharma Labs hit with FDA warning letter citing infrastructure, contamination and records problems

(06 Apr 2025)
Aspen Biopharma Labs was hit with a warning letter from the FDA outlining multiple issues at its drug ingredients manufacturing facility in...
Read more →

Tyche Industries Faces Significant Volatility Amidst Declining Financial Performance

(18 Mar 2025)
Tyche Industries, a microcap in the chemicals sector, has faced significant volatility, reaching a new 52-week low. The company has struggled over the past...
Read more →